These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 29501966

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Levodopa medication improves incidental sequence learning in Parkinson's disease.
    Beigi M, Wilkinson L, Gobet F, Parton A, Jahanshahi M.
    Neuropsychologia; 2016 Dec; 93(Pt A):53-60. PubMed ID: 27686948
    [Abstract] [Full Text] [Related]

  • 4. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
    Parkinson Study Group.
    JAMA; 2000 Oct 18; 284(15):1931-8. PubMed ID: 11035889
    [Abstract] [Full Text] [Related]

  • 5. Levodopa medication does not influence motor inhibition or conflict resolution in a conditional stop-signal task in Parkinson's disease.
    Obeso I, Wilkinson L, Jahanshahi M.
    Exp Brain Res; 2011 Sep 18; 213(4):435-45. PubMed ID: 21796541
    [Abstract] [Full Text] [Related]

  • 6. Dopaminergic medication shifts the balance between going and stopping in Parkinson's disease.
    Wylie SA, van Wouwe NC, Godfrey SG, Bissett PG, Logan GD, Kanoff KE, Claassen DO, Neimat JS, van den Wildenberg WPM.
    Neuropsychologia; 2018 Jan 31; 109():262-269. PubMed ID: 29269306
    [Abstract] [Full Text] [Related]

  • 7. Age at Parkinson's disease onset modulates the effect of levodopa on response inhibition: Support for the dopamine overdose hypothesis from the antisaccade task.
    Waldthaler J, Stock L, Krüger-Zechlin C, Timmermann L.
    Neuropsychologia; 2021 Dec 10; 163():108082. PubMed ID: 34728241
    [Abstract] [Full Text] [Related]

  • 8. The function of dopaminergic neural signal transmission in auditory pulse perception: evidence from dopaminergic treatment in Parkinson's patients.
    Geiser E, Kaelin-Lang A.
    Behav Brain Res; 2011 Nov 20; 225(1):270-5. PubMed ID: 21787806
    [Abstract] [Full Text] [Related]

  • 9. Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.
    Parkinson Study Group.
    JAMA; 2002 Apr 03; 287(13):1653-61. PubMed ID: 11926889
    [Abstract] [Full Text] [Related]

  • 10. Dopamine depletion impairs gait automaticity by altering cortico-striatal and cerebellar processing in Parkinson's disease.
    Gilat M, Bell PT, Ehgoetz Martens KA, Georgiades MJ, Hall JM, Walton CC, Lewis SJG, Shine JM.
    Neuroimage; 2017 May 15; 152():207-220. PubMed ID: 28263926
    [Abstract] [Full Text] [Related]

  • 11. Levodopa influences striatal activity but does not affect cortical hyper-activity in Parkinson's disease.
    Martinu K, Degroot C, Madjar C, Strafella AP, Monchi O.
    Eur J Neurosci; 2012 Feb 15; 35(4):572-83. PubMed ID: 22304628
    [Abstract] [Full Text] [Related]

  • 12. l-Dopa responsiveness is associated with distinctive connectivity patterns in advanced Parkinson's disease.
    Akram H, Wu C, Hyam J, Foltynie T, Limousin P, De Vita E, Yousry T, Jahanshahi M, Hariz M, Behrens T, Ashburner J, Zrinzo L.
    Mov Disord; 2017 Jun 15; 32(6):874-883. PubMed ID: 28597560
    [Abstract] [Full Text] [Related]

  • 13. Dopaminergic basis for impairments in functional connectivity across subdivisions of the striatum in Parkinson's disease.
    Bell PT, Gilat M, O'Callaghan C, Copland DA, Frank MJ, Lewis SJ, Shine JM.
    Hum Brain Mapp; 2015 Apr 15; 36(4):1278-91. PubMed ID: 25425542
    [Abstract] [Full Text] [Related]

  • 14. Effects of levodopa on corticostriatal circuits supporting working memory in Parkinson's disease.
    Simioni AC, Dagher A, Fellows LK.
    Cortex; 2017 Aug 15; 93():193-205. PubMed ID: 28675834
    [Abstract] [Full Text] [Related]

  • 15. Dopamine modulates striatal response to reward and punishment in patients with Parkinson's disease: a pharmacological challenge fMRI study.
    Argyelan M, Herzallah M, Sako W, DeLucia I, Sarpal D, Vo A, Fitzpatrick T, Moustafa AA, Eidelberg D, Gluck M.
    Neuroreport; 2018 May 02; 29(7):532-540. PubMed ID: 29432300
    [Abstract] [Full Text] [Related]

  • 16. Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET.
    Tedroff J, Pedersen M, Aquilonius SM, Hartvig P, Jacobsson G, Långström B.
    Neurology; 1996 May 02; 46(5):1430-6. PubMed ID: 8628494
    [Abstract] [Full Text] [Related]

  • 17. Cognitive deficits and striatal dopaminergic denervation in Parkinson's disease: a single photon emission computed tomography study using 123iodine-beta-CIT in patients on and off levodopa.
    Duchesne N, Soucy JP, Masson H, Chouinard S, Bédard MA.
    Clin Neuropharmacol; 2002 May 02; 25(4):216-24. PubMed ID: 12151909
    [Abstract] [Full Text] [Related]

  • 18. Brain dopaminergic modulation associated with executive function in Parkinson's disease.
    Farid K, Sibon I, Guehl D, Cuny E, Burbaud P, Allard M.
    Mov Disord; 2009 Oct 15; 24(13):1962-9. PubMed ID: 19672989
    [Abstract] [Full Text] [Related]

  • 19. The pattern of striatal dopaminergic denervation explains sensorimotor synchronization accuracy in Parkinson's disease.
    Miller NS, Kwak Y, Bohnen NI, Müller ML, Dayalu P, Seidler RD.
    Behav Brain Res; 2013 Nov 15; 257():100-10. PubMed ID: 24076152
    [Abstract] [Full Text] [Related]

  • 20. The single intake of levodopa modulates implicit learning in drug naïve, de novo patients with idiopathic Parkinson's disease.
    Geffe S, Schindlbeck KA, Mehl A, Jende J, Klostermann F, Marzinzik F.
    J Neural Transm (Vienna); 2016 Jun 15; 123(6):601-10. PubMed ID: 27106907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.